Clinical trialNCT04614740UnknownPhase 1, PHASE2Interventional

The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors

SponsorJiangsu vcare pharmaceutical technology co., LTDEnrollment115Locally Advanced Solid TumorMetastatic Solid Tumor

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

yuankai shi
Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

Anhui Provincial Cancer Hospital
Hefei, Anhui, China
Hu Li
Not, yet, recruiting
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, China
Yongsheng Li
Not, yet, recruiting
Fujian Cancer Hospital
Fuzhou, Fujian, China
Yu Chen
Not, yet, recruiting
Guangxi Medical University Affiliated Tumor Hospital
Nanning, Guangxi, China
Hongxue WangXie Weimin
Not, yet, recruiting
Hainan Cancer Hospital
Haikou, Hainan, China
Zhixia Wei
Not, yet, recruiting
the Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Da Jiang
Not, yet, recruiting
Harbin Medical Univercity Cancer Hospital
Harbin, Heilongjiang, China
Qingyuan Zhang
Not, yet, recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China
Jiaqiang WangSuxia Luo
Recruiting
Hunan Cancer Hospital
Changsha, Hunan, China
Gang Huang
Recruiting
Jiangsu Province Hospital of Chinese Medicine
Nanjing, Jiangsu, China
Jun Qian
Recruiting
Shandong Cancer Hospital
Jinan, Shandong, China
Dongyuan Zhu
Not, yet, recruiting
Shanghai Tenth People'S Hospital
Shanghai, Shanghai Municipality, China
Qing Xu
Not, yet, recruiting
Shanxi Provincial Cancer Hospital
Taiyuan, Shanxi, China
Shuqing Wei
Not, yet, recruiting
Yunnan Cancer Hospital
Kunming, Yunnan, China
Yanbin Xiao
Not, yet, recruiting
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Meiyu Fang
Not, yet, recruiting
Cancer Hospital,chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China
Yuankai Shi
Recruiting
Zhujiang Hospital of Southern Medical University
Guangzhou, China
Ting Wei
Recruiting
Liaoning Cancer Hospital & Institute
Shenyang, China
Zhendong Li
Recruiting
Tianjin Cancer Hospital
Tianjin, China
Guowen Wang
Recruiting
Hubei Cancer Hospital
Wuhan, China
Youhua Zhu
Recruiting
the First Affiliated Hospital of Xinjiang Medical University
Ürümqi, China
Huarong Zhao
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 20 Nov 2020
Primary completion: 31 Jan 2024
Completion: 30 Jun 2024
Last update posted: 13 Dec 2022
Registered enrollment: 115
Registry id: NCT04614740

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.